510(k) SummaRY

1.Date:

July 15, 2014

JUL 1 7 2014

2. Submitter:

HEALGEN SCIENTIFIC LLC   
5213 Maple St   
Bellaire, TX77401

Contact person:

Jianqiu Fang   
HEALGEN SCIENTIFIC LLC   
5213 Maple St   
Bellaire, TX77401   
Telephone: 713-733-8088   
Fax: 713-733-8088   
Email: bryan@healgen.com

Device Name: Healgen COC One Step Cocaine Test (Strip, Cassette, Cup, Dip Card) Healgen MOP One Step Morphine Test (Strip, Cassette, Cup, Dip Card)

Classification:

<table><tr><td rowspan=1 colspan=1>ProductCode  I</td><td rowspan=1 colspan=1>CFR #</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>DIO</td><td rowspan=1 colspan=1>21 CFR, 862.3250 Cocaine Test System</td><td rowspan=1 colspan=1>Toxicology</td></tr><tr><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>21 CFR, 862.3650 Opiate Test System</td><td rowspan=1 colspan=1>Toxicology</td></tr></table>

5Predicate Devices:

K052115   
First Check Multi Drug Cup 12

Intended Use

Healgen COC One Step Cocaine Test is an immunochromatographic assay for the qualitative determination of Benzoylecgonine in human urine at a Cut-Off concentration of $3 0 0 ~ \mathrm { n g / m L }$ . The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format.

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. It is intended for over-the-counter and for prescription use.

Healgen MOP One Step Morphine Test is an immunochromatographic assay for the qualitative determination of morphine in human urine at a Cut-Off concentration of $3 0 0 ~ \mathrm { \ n g / m L }$ . The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format.

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. It is intended for over-the-counter and for prescription use.

# Device Description

Healgen COC One Step Cocaine Test and Healgen MOP One Step Morphine Test are immunochromatographic assays for Cocaine and Morphine. Each assay test is a lateral flow, one step system for the qualitative detection of Benzoylecgonine and Morphine (target analyte) in human urine. The product is a single-use in vitro diagnostic device, which comes in the form o Strips, Cassttes, DipCards, or Cups. It contains a Test Device (in one of the four formats), a package insert and a urine cup. Each test device is sealed with a desiccant in an aluminum pouch.

8. Substantial Equivalence Information A summary comparison of features of the One Step Cocaine Test and One Step Morphine Test and the predicate device is provided in Table I & Table 2.

Table 1: Features Comparison of Healgen COC One Step Cocaine Test and the Predicate Device   

<table><tr><td rowspan=1 colspan=1>v   Itemh  $i=$   t</td><td rowspan=1 colspan=1>tteve1.6  Device</td><td rowspan=1 colspan=1>Predicate{vr:9             4    K052115</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitative determination ofBenzoylecgonine in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays based onthe principle of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cut-Off Values</td><td rowspan=1 colspan=1>300 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>IntendedPopulation</td><td rowspan=1 colspan=1>For over-the-counter and prescriptionuses.</td><td rowspan=1 colspan=1>Forover-the-counteruse.</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Strip, Cassette, Cup, Dip Card</td><td rowspan=1 colspan=1>Cup</td></tr></table>

Table 2: Features Comparison of Healgen MOP One Step Morphine Test and the Predicate Device   

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate - K052115</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitative determination ofMorphine in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays basedon the principle of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cut-Off Values</td><td rowspan=1 colspan=1>300 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>IntendedPopulation</td><td rowspan=1 colspan=1>For over-the-counter and prescriptionuses.</td><td rowspan=1 colspan=1>For over-the-counteruse.</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Strip, Cassette, Cup, Dip Card</td><td rowspan=1 colspan=1>Cup</td></tr></table>

# Test Principle

Healgen COC One Step Cocaine Test and Healgen MOP One Step Morphine Test are rapid tests for the qualitative detection of Benzoylecgonine and Morphine in urine samples. Each assay test is a lateral flow chromatographic immunoassay. During testing, a urine specimen migrates upward by capillary action. If target drugs are present in the urine specimen below its cut-off concentration, it will not saturate the binding sites of its speciic antibody (monoclonal mouse antibody) coated on the particles. The antibody-coated particles will then be captured by immobilized drug-conjugate and a visible colored i wil showu i the t ne reg.The colre ie will not frm  the s ie gion  the e drug level exceeds its cutoff-concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices regardless of the presence of drug or metabolite in the sample.

10. Performance Characteristics

1. Analytical Performance

a. Precision

Precision studies were carried out for samples with concentrations of. $100 \%$ cut-off, $- 7 5 \%$ cut-off, $5 0 \%$ cut-off, $- 2 5 \%$ cut-off, at the cut-off $+ 2 5 \%$ cut-off, $+ 5 0 \%$ cut-off, $+ 7 5 \%$ cut-off and $+ 1 0 0 \%$ EY cut-off. These samples were prepared by spiking drug in negative samples. Each drug concentration was confirmed by GC/MS. All sample aliquots were blinded labeled and randomized.

For each concentration, tests were performed two runs per day for 25 days. The results obtained are summarized in the following tables:

Cocaine (COC) Strip Format   

<table><tr><td rowspan=1 colspan=1>ResultDrug</td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111001</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111002</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111003</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

COC Cassette Format   

<table><tr><td rowspan=1 colspan=1>ResultDrug</td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111004</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111005</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111006</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

COC Dip Card Format   

<table><tr><td rowspan=1 colspan=1>ResultDrug</td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111007</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111008</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111009</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

# COC CUP Format

<table><tr><td rowspan=1 colspan=1>ResultDrug</td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111010</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111011</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:COC1111012</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Morphine (MOP) Strip Format   

<table><tr><td colspan="1" rowspan="1">ResultDrug</td><td colspan="1" rowspan="1">-100%Cut-off</td><td colspan="1" rowspan="1">-75%Cut-off</td><td colspan="1" rowspan="1">-50%Cut-off</td><td colspan="1" rowspan="1">-25%Cut-off</td><td colspan="1" rowspan="1">Cut-off</td><td colspan="1" rowspan="1">+25%Cut-off</td><td colspan="1" rowspan="1">+50%Cut-off</td><td colspan="1" rowspan="1">+75%Cut-off</td><td colspan="1" rowspan="1">+100%Cut-off</td></tr><tr><td colspan="1" rowspan="1">Lot:MOP1110001</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">16-/34+</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td></tr><tr><td colspan="1" rowspan="1">Lot:MOP1110002</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">16-/34+</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td></tr><tr><td colspan="1" rowspan="1">Lot:MOP1110003</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">50-/0+</td><td colspan="1" rowspan="1">16-/34+</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td><td colspan="1" rowspan="1">50+/0-</td></tr></table>

# MOP Cassette Format

<table><tr><td>Result</td><td>-100%</td><td>-75%</td><td>-50%</td><td>-25%</td><td>Cut-off</td><td>+25%</td><td>+50%</td><td>+75%</td><td>+100%</td></tr><tr><td>Drug</td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td><td></td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td></tr><tr><td>Lot:MOP1110004</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>18-/32+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot:MOP1110005</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>18-/32+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot:MOP1110006</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>18-/32+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr></table>

MOP Dip Card Format   

<table><tr><td>Result</td><td>-100%</td><td>-75%</td><td>-50%</td><td>-25%</td><td>Cut-off</td><td>+25%</td><td>+50%</td><td>+75%</td><td>+100%</td></tr><tr><td>Drug</td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td><td></td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td><td>Cut-off</td></tr><tr><td>Lot:MOP1110007</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>22-/28+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot:MOP1110008</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>22-/28+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot:MOP1110009</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>22-/28+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr></table>

# MOP CUP Format

<table><tr><td rowspan=1 colspan=1>ResultDrug</td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot:MOP1110010</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:MOP1110011</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot:MOP1110012</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

b. Linearity

Not applicable, these are visually read devices.

c. Stability

The devices are stable at $4 { - } 3 0 ^ { \circ } \mathbb { C }$ for 24 months based on the accelerated stability study at $4 5 \%$ and real time stability determination at both $4 \textdegree C$ and $3 0 \%$ .

Control materials are not provided with the device. The labeling provides information on how to obtain control materials.

# d. Cut-off

A total of 150 samples equally distributed at concentrations of $- 5 0 \%$ cut-off; $2 5 \%$ cut-off; cut-off $+ 2 5 \%$ cut-off; $+ 5 0 \%$ cut-off were tested using three different lots of each device by three different operators. Results were all positive at and above $+ 2 5 \%$ cut-off and all negative at and

below $- 2 5 \%$ cut-off for both Cocaine and Morphine. The following cut-off values for the test devices have been verified.

<table><tr><td rowspan=1 colspan=1>Test</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Cut-off(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>One Step Cocaine Test</td><td rowspan=1 colspan=1>Benzoylecogonine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>One Step Morphine Test</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>300</td></tr></table>

# e. Interference

Potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and target drugs urine with concentration at $2 5 \%$ below and $25 \%$ above cut-off levels. These urine samples were tested using three batches of each device for all formats.

Compounds that showed no interference at a concentration of $1 0 0 \mu \mathrm { g / m L }$ are summarized in the following tables. There were no differences observed for different formats.

COC   

<table><tr><td colspan="1" rowspan="1">4-Acetamidophenol</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Pentazocine</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Amitryptyline</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">L-Phenylephrine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">β-Phenylethlamine</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">β-Phenyllethylamine</td></tr><tr><td colspan="1" rowspan="1">D,L-Amphetamine</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Prednisolone</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Iproniazid</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">(-) Isoproterenol</td><td colspan="1" rowspan="1">Procaine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">D,L-Propanolol</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">D-Propoxyphene</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">D-Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">(+)3,4-Methylenedioxyamphetamine</td><td colspan="1" rowspan="1">Serotonin(5-Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">(±) Chlorpheniramine</td><td colspan="1" rowspan="1">(+)3,4-Methylenedioxymethamphetamine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chlorquine</td><td colspan="1" rowspan="1">Methyprylon</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Morphine-3-β-Dglucuronide</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">Tetrahydrocortisone,3Acetate</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Tetrahydrocortisone3(5-Dglucuronide)</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Thebaine</td></tr><tr><td colspan="1" rowspan="1">(-) Cotinine</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">D, L-Thyroxine</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Norcodein</td><td colspan="1" rowspan="1">Tolbutamine</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">11-nor-Δ9-THC-9-COOH</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">D,L-Octopamine</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Oxalic acid</td><td colspan="1" rowspan="1">D, L-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Ecgonine hydrochloride</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Oxolinic acid</td><td colspan="1" rowspan="1">D, L-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">(-) Y Ephedrine</td><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Oxymetazoline</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Papaverine</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Penicillin-G</td><td colspan="1" rowspan="1"></td></tr></table>

MOP   

<table><tr><td colspan="1" rowspan="1">Acebutolol</td><td colspan="1" rowspan="1">(-) Y Ephedrine</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td></tr><tr><td colspan="1" rowspan="1">Acetopromazine -d6</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">4-Acetamidophenol</td><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">Penicillin-G</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Pentazocaine</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">D.L-Amphetamine</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Amitryptyline</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">β-Phenyllethylamine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">L-Phenylephrine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">β-Phenylethlamine</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Prednisolone</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Iproniazid</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">(-) Isoproterenol</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">D,L-Propanolol</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">D-Propoxyphene</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">D-Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Serotonin</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">(+)3,4-Methylenedioxyamphetamine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">(±) Chlorpheniramine</td><td colspan="1" rowspan="1">(+)3,4-Methylenedioxymethamphetamine</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chlorquine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Methyprylon</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">Tetrahydrocortisone,3 Acetate</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Tetrahydrocortisone3(5-Dglucuronide)</td></tr><tr><td colspan="1" rowspan="1">Cocaine hydrochloride</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">(-) Cotinine</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">D,L-Thyroxine</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Tolbutamine</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Norcodein</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">D,L-Octopamine</td><td colspan="1" rowspan="1">D, L-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Oxalic acid</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Ecgonine hydrochloride</td><td colspan="1" rowspan="1">Oxolinic acid</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Oxymetazoline</td><td colspan="1" rowspan="1"></td></tr></table>

# f. Specificity

To test the specificity, drug metabolites and other components that are likely to interfere in urine samples were tested using three batches of each device for all formats. The obtained lowest detectable concentration was used to calculate the cross-reactivity. There were no differences observed for different formats.

<table><tr><td rowspan=1 colspan=1>COC(Benzoylecogonine,Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>ResultPositive at 300 ng/mL</td><td rowspan=1 colspan=1>%Cross-Reactivity100%</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Cocaine HCl</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>MOP(Morphine, Cut-off=300ng/mL)</td><td rowspan=1 colspan=1>ResultPositive at 300 ng/mL</td><td rowspan=1 colspan=1>%Cross-Reactivity100%</td></tr><tr><td rowspan=1 colspan=1>6-Acetylmorphine</td><td rowspan=1 colspan=1>Positive at 400 ng/mL</td><td rowspan=1 colspan=1>75%</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>EthylMorphine</td><td rowspan=1 colspan=1>Positive at 6240 ng/mL</td><td rowspan=1 colspan=1>5%</td></tr><tr><td rowspan=1 colspan=1>Heroin</td><td rowspan=1 colspan=1>Positive at 600 ng/mL</td><td rowspan=1 colspan=1>50%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>Positive at 3120 ng/mL</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>Positive at 50000 ng/mL</td><td rowspan=1 colspan=1>0.6%</td></tr><tr><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>Positive at 1500 ng/mL</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Positive at 30,000 ng/mL</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>Procaine</td><td rowspan=1 colspan=1>Positive at 15,000 ng/mL</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>Positive at 6240 ng/mL</td><td rowspan=1 colspan=1>5%</td></tr></table>

# g. Effect of Urine Specific Gravity and Urine pH

To investigate the effect of urine specific gravity and urine $\mathsf { p H }$ , urine samples with of 1.000 to 1.035 specific gravity or urine samples with ${ \mathsf { p H } } 4$ to 9 were spiked with target drugs at $2 5 \%$ E below and $2 5 \%$ above cut-off levels. These samples were tested using three batches of each device for all formats. Results were all positive for samples at and above $+ 2 5 \%$ cut-off and all negative for samples at and below $- 2 5 \%$ Cut-Off. There were no differences observed for different formats.

2 Comparison Studies

The method comparison studies for the One Step Cocaine Test, and the One Step Morphine Test were performed in-house with three different laboratory assistants for each format of the device. Operators ran 80 (40 negative and 40 positive) unaltered clinical samples. The samples were blind labeled and compared to GC/MS results. The results are presented in the tables below:

COC   

<table><tr><td rowspan=1 colspan=1>Stripformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>NearCutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of COC Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Discordant Results of COC Cassette   

<table><tr><td rowspan=1 colspan=1>Cassetteformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>NearCutoffNegativeby GC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Discordant Results of COC Cup   

<table><tr><td rowspan=1 colspan=1>Cupformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Discordant Results of COC Dip Card   

<table><tr><td rowspan=1 colspan=1>Dip Cardformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

MOP   

<table><tr><td rowspan=1 colspan=1>Stripformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than.50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MOP Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>328</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Cassetteformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MOP Cassette   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>310</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Dip Cardformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MOP Dip Card   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>310</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>310</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td>Cup format</td><td></td><td>Negative</td><td>Low Negative by GC/MS (less than -50%)</td><td>Near Cutoff Negative by GC/MS (Between -50% and</td><td>Near Cutoff Positive by GC/MS (Between the cut-off</td><td>High Positive by GC/MS (greater than</td></tr><tr><td>Viewer A</td><td>Positive</td><td>0</td><td>0</td><td>cut-off) 0</td><td>and +50%) 14</td><td>+50%) 25</td></tr></table>

Discordant Results of MOP Cup   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>StripFormatViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Lay-user study

A lay user study was performed at three intended user sites with 140 lay persons testing the cocaine devices and another set of 140 persons testing the morphine devices. A total of 56 females and 84 males tested the Cocaine samples, and 53 females and 87 males tested the Morphine samples. They had diverse educational and professional backgrounds and ranged in age from 21 to $> 5 0$ years. Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \% , + / - 5 0 \% , + / - 2 5 \%$ of the cutoff by spiking drugs into drug free-pooled urine specimens. The concentrations of the samples were confirmed by GC/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled sample and a device. The results are summarized below.

Comparison between GC/MS and Lay Person Results (COC Strip)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>COC Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (COC Cassette)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>COC Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (COC DipCard)   

<table><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>COC Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (COC Cup)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>COC Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (MOP Strip)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>MOP Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (MOP Cassette)   

<table><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>MOP Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (MOP DipCard)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>MOP Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (MOP Cup)   

<table><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Numberofsamples</td><td colspan="1" rowspan="2">MOP Concentration byGC/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">Thepercentage ofcorrect results(%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100%Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">-75%Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">-25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95%</td></tr><tr><td colspan="1" rowspan="1">+25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">+75%Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">525</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr></table>

Lay-users were also given surveys on the ease of understanding the package insert instructions. All lay users indicated that the device instructions can be easily followed. A Flesch-Kincaid reading analysis was performed on each package insert and the scores revealed a reading Grade Level of 7.

# 3. Clinical Studies

Not applicable.

# 11.Conclusion

Based on the test principle and acceptable performance characteristics including precision, cut-off, interference, specificity and method comparison of the devices, it's concluded that the Healgen COC One Step Cocaine Test, and Healgen MOP One Step Morphine Test are substantially equivalent to the predicate.

July 17, 2014

HEALGEN SCIENTIFIC. LLC C/O JOE SHIA LSI INTERNATIONAL INC 504 EAST DIAMOND AVE. SUITE F GAITHERSBURG MD 20877

Re: K141647 Trade/Device Name: Healgen COC One Step Cocaine Test (Strip, Casste. Dip Card, Cup) Healgen MOP One Step Morphine Test (Strip. Cassette, Dip Card. Cup) Regulation Number: 21 CFR 862.3250 Regulation Name: Cocaine and cocaine metabolite test system Regulatory Class: II Product Code: DIO. DJG Dated: June 16, 2014 Received: June 19, 2014

Dear Mr. Joe Shia:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28. 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may. therefore. market the device. subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices. good manufacturing practice, labeling. and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you. however. that device labeling must be truthful and not mislcading.

If your device is classified (see above) into cither class II (Special Controls) or class I| (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with al the Act's requirements. including. but not limited to: registration and listing (21 CFR Part 807): labcling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803): good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable. the

electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000- 1050.

If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/MedicalDevices/ResourcesforYou/lndustry/default.htm.Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part .o q grghor ve nd h  uat 1 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safcty/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDeviccs/ResourcesforYou/Industry/default.htm.

Sincerely yours.

# Katherine Serrano -S

For: Courtney H. Lias. Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Device Name Healgen MOP One Step Morphine Test (Strip, Cassettc, Dip Card, Cup) Healgen COC One Step Cocaine Test (Strip. Cassette, Dip Card. Cup)

Indications for Use (Describe)   
Healgen COC One Step Cocaine Test is an immunochromatographic assay for the qualitative determination of Benenie nhuan rie  Cuntratio 300LThe  is vailablen  Sti Cassette format, a Dip Card format and a Cup format.

The  pr eaum peavemeus alyu eeCci o u u For in vito diagnostic use nly. It is intended or over-the-counter and or presciption use.

HealgnOS Moharaphiy he ualatvetti in human urine at a Cut-Off concentration of $3 0 0 n g / m L$ T Card format and a Cup format.

The  viey  um eativem meus u For in vitro diagnostic use only. It is intended for over-the-counter and for prescription use.